Milenko Cicmil

Milenko Cicmil is a highly experienced professional in the field of pharmacology and biomedical research, currently serving as a Visiting Research Fellow at the University of Reading since June 2020. Milenko is also a Partner at Cure Ventures and previously held the position of Chairman of the Board at AMP Discovery from February 2021 to January 2022. With a robust background in leadership roles at Ipsen, FogPharma, and Merck, Milenko has contributed extensively to advancements in external innovation, translational biology, and pharmacology. A former senior researcher at AstraZeneca and GE Healthcare, Milenko's career began with a research fellowship at Cancer Research UK. Educationally, Milenko earned a Bachelor's Degree in Cell/Cellular and Molecular Biology from King's College London and a Ph.D. in Molecular Pharmacology from the University of Reading.